Description: Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. It also provides various therapeutic products, including general anaesthetics and muscle relaxants; and injectable anticoagulants comprising orgaran for the treatment of HIT and heparin based products under the Thrombosis brand. In addition, the company offers oncology, endocrinology, and women's health products, as well as nutritional infant milks. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Home Page: www.aspenpharma.com
Aspen Place
Durban,
South Africa
Phone:
27 31 580 8600
Officers
| Name | Title |
|---|---|
| Mr. Stephen Bradley Saad BCom, CA(SA) | Group CEO & Executive Director |
| Mr. Sean M. Capazorio | Group CFO & Executive Director |
| Ms. Lorraine Hill | Group Chief Operations Officer & Responsible Pharmacist |
| Mr. Michael Guy Attridge B.Com., CA(SA) | Group Chief Advisor |
| Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA | Group Chief Corporate Services Officer & Executive Director |
| Ms. Zizipho Mmango | Group Chief Strategic Development Officer |
| Sibongakonke Nkosi | Investor Relations Manager |
| Mr. Trevor Julian Ziman | Regional Chief Executive Officer of Asia Pacific |
| Mr. Samer Kassem | Chief Executive Officer of Aspen Global Incorporated |
| Ms. Raeesa Khan | Group Company Secretary |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 20.0738 |
| Price-to-Book MRQ: | 1.135 |
| Price-to-Sales TTM: | 0.1217 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |